SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-050526
Filing Date
2017-02-21
Accepted
2017-02-21 16:59:02
Documents
2
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 6-K d347890d6k.htm 6-K 10909
2 EX-99.1 d347890dex991.htm EX-99.1 202070
  Complete submission text file 0001193125-17-050526.txt   213984
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 17625793
SIC: 2834 Pharmaceutical Preparations